325 related articles for article (PubMed ID: 25983002)
1. Inhibition of LDHA suppresses tumor progression in prostate cancer.
Xian ZY; Liu JM; Chen QK; Chen HZ; Ye CJ; Xue J; Yang HQ; Li JL; Liu XF; Kuang SJ
Tumour Biol; 2015 Sep; 36(10):8093-100. PubMed ID: 25983002
[TBL] [Abstract][Full Text] [Related]
2. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells.
Rong Y; Wu W; Ni X; Kuang T; Jin D; Wang D; Lou W
Tumour Biol; 2013 Jun; 34(3):1523-30. PubMed ID: 23404405
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma.
Gao S; Tu DN; Li H; Jiang JX; Cao X; You JB; Zhou XQ
Biomed Pharmacother; 2016 Jul; 81():388-393. PubMed ID: 27261617
[TBL] [Abstract][Full Text] [Related]
4. A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer.
Shi M; Cui J; Du J; Wei D; Jia Z; Zhang J; Zhu Z; Gao Y; Xie K
Clin Cancer Res; 2014 Aug; 20(16):4370-80. PubMed ID: 24947925
[TBL] [Abstract][Full Text] [Related]
5. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
6. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma.
Li J; Zhu S; Tong J; Hao H; Yang J; Liu Z; Wang Y
Neuroreport; 2016 Jan; 27(2):110-5. PubMed ID: 26694942
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
9. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.
Le A; Cooper CR; Gouw AM; Dinavahi R; Maitra A; Deck LM; Royer RE; Vander Jagt DL; Semenza GL; Dang CV
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2037-42. PubMed ID: 20133848
[TBL] [Abstract][Full Text] [Related]
11. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S
J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of LDHA Deliver Potential Anticancer Performance in Renal Cell Carcinoma.
Wang X; Xu L; Wu Q; Liu M; Tang F; Cai Y; Fan W; Huang H; Gu X
Urol Int; 2017; 99(2):237-244. PubMed ID: 27027898
[TBL] [Abstract][Full Text] [Related]
14. LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma.
Yao F; Zhao T; Zhong C; Zhu J; Zhao H
Tumour Biol; 2013 Feb; 34(1):25-31. PubMed ID: 22961700
[TBL] [Abstract][Full Text] [Related]
15. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
[TBL] [Abstract][Full Text] [Related]
16. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression.
Cheng CS; Tan HY; Wang N; Chen L; Meng Z; Chen Z; Feng Y
Clin Transl Med; 2021 Jun; 11(6):e467. PubMed ID: 34185423
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells.
Zhang W; Wang C; Hu X; Lian Y; Ding C; Ming L
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35191522
[TBL] [Abstract][Full Text] [Related]
18. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.
Jiang W; Zhou F; Li N; Li Q; Wang L
Int J Clin Exp Pathol; 2015; 8(6):6756-63. PubMed ID: 26261559
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A
Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084
[TBL] [Abstract][Full Text] [Related]
20. ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
Chen G; Cai ZD; Lin ZY; Wang C; Liang YX; Han ZD; He HC; Mo RJ; Lu JM; Pan B; Wu CL; Wang F; Zhong WD
Mol Carcinog; 2020 Aug; 59(8):897-907. PubMed ID: 32319143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
